Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis

ConclusionsHypergammaglobulinemia identifies C‐P class A cirrhotic patients at higher risk of disease progression, HCC development and death.This article is protected by copyright. All rights reserved.
Source: Liver International - Category: Gastroenterology Authors: Tags: Original Article Source Type: research